Tenacissoside I
CAS: 191729-44-9
Ref. 3D-FT74349
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- (3β,5α,11α,12β,14β,17α)-12-Acetoxy-3-{[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy}-20-oxo-8,14-epoxypregnan-11-yl benzoate
- Pregnan-20-one, 12-(acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-β-D-allopyranosyl)-3-O-methyl-β-D-arabino-hexopyranosyl]oxy]-8,14-epoxy-, (3β,5α,11α,12β,14be ta,17α)-
- (3beta,5alpha,11alpha,12beta,14beta,17alpha)-12-(Acetyloxy)-11-(benzoyloxy)-3-[[2,6-dideoxy-4-O-(6-deoxy-3-O-methyl-beta-D-allopyranosyl)-3-O-methyl-beta-D-arabino-hexopyranosyl]oxy]-8,14-epoxypregnan-20-one
- Tenacissimoside B
Tenacissoside I is a polyhydroxylated triterpene compound derived from the Chinese herb, Tenacissus. It has been shown to have an anticancer activity by binding to epidermal growth factor receptor and blocking the downstream signaling pathway. Tenacissoside I has also been found to inhibit glucose uptake in human liver cells. This drug is then metabolized into tenacissoside II and tenacissoside III, which are also active compounds. Tenacissoside I inhibits protein synthesis by competing with insulin for its receptor on the surface of cells, which results in a decreased glucose uptake.
Propiedades químicas
Consulta técnica sobre: 3D-FT74349 Tenacissoside I
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
